Enhancement of anti-proliferative activities of 5-FU, HCFU, SN-38, THP and ACNU by a serine protease inhibitor, FOY-305

International Journal of Oncology

Volumn 9, Issue 3, 1996, Pages 517-520

  Hiwasa, Takaki ^a   Tokita, Hisashi ^a   Hirose, Masayoshi ^a   Ike, Yoshimasa ^b   Ohkoshi, Motohiro ^c  

^a CHIBA CANCER CENTER   (Japan)

^b MITSUI CHEMICALS INC   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

5 FU; anticancer drug; FOY 305; MTI assay; ras oncogene; serine protease inhibitor

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CAMOSTAT MESILATE; CARMOFUR; FLUOROURACIL; IFOSFAMIDE; MITOXANTRONE; NIMUSTINE; PIRARUBICIN; SERINE PROTEINASE INHIBITOR; VINCRISTINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE PHASE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG POTENTIATION; FLOW CYTOMETRY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION;

EID: 0029810012     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.3.517     Document Type: Article

References (30)

1. Hiwasa T: Gene sharing of protease inhibitors. In: Proteases Involved in Cancer. Suzuki M and Hiwasa T (eds). Monduzzi Editore, Bologna, pp153-160, 1995.
2. Rossman TG and Troll W: Protease inhibitors in carcinogenesis: In: Carcinogenesis: Modifiers of Chemical Carcinogenesis. Slaga TG (ed). Raven Press, New York, pp127-143, 1980.
3. Troll W, Klassen A and Janoff A: Tumorigenesis in mouse skin: Inhibition by synthetic inhibitors of proteases. Science 169: 1211-1213, 1970.
4. Weed H, McGandy RB and Kennedy AR: Protection against dimethylhydrazine induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Carcinogenesis 6: 1239-1241, 1985.
5. Witschi H and Kennedy AR: Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor. Carcinogenesis 10: 2275-2277, 1989.
6. St Clair W, Billing P, Carew J, Keller-McGandy C, Newberne P and Kennedy AR: Suppression of DMH-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Res 50: 580-586, 1990.
7. Kennedy AR: Anticarcinogenic activity of protease inhibitors. In: Protease Inhibitors as Cancer Chemopreventive Agents. Troll W and Kennedy AR (eds). Plenum Press, New York, pp9-64, 1993.
8. Tamura Y, Hirano M, Okamura K, Minato Y and Fujii S: Synthetic inhibitor of trypsin, plasmin, kallikrein, thrombin, Cir C1 elastase. Biochim Biophys Acta 484: 417-422, 1977.
9. Ohkoshi M: Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl, 4-(4-guanidinobenzoyloxy)-phenylacetate]methanesulfate. Jpn J Cancer Res 72: 959-964, 1981.
10. Ohkoshi M and Fujii S: Effect of oral administration of protease inhibitor [N,N-dimethylcarbamoylmethyl, 4-(4-guanidinobenzoyloxy)-phenylacetate]methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice. Jpn J Cancer Res 73: 108-110, 1982.
11. Ohkoshi M and Fujii S: Effect of the synthetic protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate]methanesulfate on carcinogenesis by 3-methylcholanthrene in mouse skin. J Natl Cancer Inst 71: 1053-1057, 1983.
12. Ohkoshi M, Akagawa T and Nakajima M: Effects of serine protease inhibitor FOY-305 and heparin on the growth of squamous cell carcinoma. Anticancer Res 13: 963-966, 1993.
13. Ohkoshi M and Oka T: Clinical experience with a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate]methanesulfate for prevention of recurrence of carcinoma of the mouse and in treatment of terminal carcinoma. J Max-Fac Surg 12: 148-152, 1984.
14. Ohkoshi M: Protease inhibitors as anticancer drug: experimental and clinical study with serine protease inhibitors; In: Proteases Involved in Cancer. Suzuki M and Hiwasa T (eds). Monduzzi Editore, Bologna, pp125-127, 1995.
15. Yuasa Y, Oto M, Sato C, Miyaki M, Iwama T, Tonomura A and Namba M: Colon carcinoma K-ras2 oncogene of a familial polyposis coli patient. Jpn J Cancer Res 77: 901-907, 1986.
16. Akiyama T, Matsuda S, Namba M, Saito T, Toyoshima K and Yamamoto T: The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxy-terminal domain. Mol Cell Biol 11: 833-842, 1991.
17. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
18. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA and Coffman RL: Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357, 1986.
19. Mosmann TR and Fong TAT: Specific assays for cytokine production by T cells. J Immunol Methods 116: 151-158, 1989.
20. Hiwasa T, Soeda C, Takanohashi S, Kobayashi H, Suzuki A, Ueyama T and Ike Y: Screening of peptides which suppress the proliferation of transformed cells. Int J Oncol 8: 125-129, 1996.
21. Tate EH, Wilder ME, Cram S and Wharton W: A method for staining 3T3 cell nuclei with propidium iodide in hypotonic solution. Cytometry 4: 211-215, 1983.
22. Ozaki T, Nakamura Y, Enomoto H, Hirose M and Sakiyama S: Overexpression of DAN gene product in normal rat fibroblasts causes a retardation of the entry into the S phase. Cancer Res 55: 895-900, 1995.
23. Lowy DR and Willumsen BM: Function and regulation of ras. Annu Rev Biochem 62: 851-891, 1993.
24. Bos JL: Ras oncogenes in human cancer: A Review. Cancer Res 49: 4682-4689, 1989.
25. Kiaris H and Spandidos DA: Mutations of ras genes in human tumours (Review). Int J Oncol 7: 413-421, 1995.
26. Hiwasa T: Ras inhibitors. Oncol Rep 3: 7-14, 1996.
27. Erpel T and Courtneidge SA: Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 7: 176-182, 1995.
28. Hanks SK, Quinn AM and Hunter T: The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52, 1988.
29. Uehara Y, Hori M, Takeuchi T and Umezawa H: Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': Identification of an active agent as herbimycin and its inhibition of intracellular src kinase. Jpn J Cancer Res76: 672-675, 1985.
30. Akiyama T, Ishida J, Nakagawa S, Ogawa H, Watanabe S, Itou N, Shibata M and Fukumi Y: Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 262: 5592-5595, 1987.